James P Allison: Béda antara owahan

Konten dihapus Konten ditambahkan
besut artikel
besut artikel
Larik 1:
'''James P Allison'''<ref>{{Cite news|url=https://faculty.mdanderson.org/profiles/james_allison.html|title=https://faculty.mdanderson.org/profiles/james_allison.html|last=|first=|date=|work=|access-date=|archive-url=|archive-date=|dead-url=}}</ref> (mijil 7 Agustus 1948) inggih menika ''profesor'' wonten ing ''University of Texas MD Anderson Cancer center'', ''[[Huston, Texas, Amerika Serikat]].'' Jamesbiasanipun Pasring Allison damel panaliten gayut obat kangge kanker ganas kaliyan Tasuku Honjo ingkang saking ''[[Jepang]]''. Hasilipun panaliten menika dadosaken dokter-doker langkung gampil anggenipun ngobati tiyang ingkang gerah [[kanker]]. Panemunipun James Pdipunsebat Allison kaliyan Tasuku Honjo menika gadhahi nama ''immune checkpoint therapy''. kanthi panalitèn menika, James P Allison saha kancanipun angsal bebingah Nobel nalika dinten Senin, 1 oktober 2018 wonten ing ''[[Karolinska Institutet, Stockholm]]''
 
== '''Karier''' ==
Nalika dipuncaosi kabar bilih James menika dados juara, James boten saged dipunkabari lajeng saweg saged dipunkabari kalihan wartawan nalika énjing kanthi nelpon putranipun James. Ananging James boten wonten amargi tindak dhateng [[New York]] wonten ing adicara ''Konfrensi Imunologi''.
James P Allison damel panaliten gayut obat kangge kanker ganas kaliyan Tasuku Honjo ingkang saking ''[[Jepang]]''. Hasilipun panaliten menika dadosaken dokter-doker langkung gampil anggenipun ngobati tiyang ingkang gerah [[kanker]]. Panemunipun James P Allison kaliyan Tasuku Honjo menika gadhahi nama ''immune checkpoint therapy''. kanthi panalitèn menika, James P Allison saha kancanipun angsal bebingah Nobel nalika dinten Senin, 1 oktober 2018 wonten ing ''[[Karolinska Institutet, Stockholm]]''
 
Nalika dipuncaosi kabar bilih JamesAllison menika dados juara, James boten saged dipunkabari lajeng saweg saged dipunkabari kalihan wartawan nalika énjing kanthi nelpon putranipun JamesAllison. Ananging Jamespiyambakipun boten wonten amargi nembe tindak dhateng [[New York]] wonten ing adicara ''Konfrensi Imunologi''.
Kawruhipun James kawiwitan nalika taun 1990, panjenenganipun nindakaken  ''riset'' wonten ing salah satunggalipun ''protein sel T,''inggih menika '' CTLA_4'' wonten ing [[Laboratorium University of California|''Laboratorium University of California'']]'', Barkeley,'' protein menika nggadhahi fungsi kadosta rem ingkang saged ngèndelaken ''aktivasi  sel T''  nalika merangi sel kanker. James ngembangaken ''antibodi'' ingkang saged rumaket wonten ing  ''CTLA-4'' saha ngèndelaken fungsinipun.
 
Kawruhipun JamesAllison kawiwitan nalika taun 1990, panjenenganipun nindakaken  ''riset'' wonten ing salah satunggalipun ''protein sel T,''inggih menika '' CTLA_4'' wonten ing [[Laboratorium University of California|''Laboratorium University of California'']]'', Barkeley,. sel T'' saged dipunwastani ... protein menika nggadhahi fungsi kadosta rem ingkang saged ngèndelaken ''aktivasi  sel T''  nalika merangi sel kanker. JamesPiyambakipun ngembangaken ''antibodi'' ingkang saged rumaket wonten ing  ''CTLA-4'' saha ngèndelaken fungsinipun''fungsi-''nipun. Nalika ''fungsi CTLA-4'' katutup kaliyan ''antibodi'' menika, dayanipun badan mawi ''sel T''
 
Kancanipun James wonten ing ''[[University of California]]'', Prof. Sergio Quezada gambaraken bilih James menikatiyang ingkang sae sanget, nggadhahi sifat andhap asor saha dados ''mentor'' ingkang beda kaliyan sanès-sanèsipun.
 
== PendhidhikanPendidikan: ==
PhD saking University of Texas taun 1973, Postdoctoral fellow wonten ing The Scripps Clinic and Research Foundation, La Jolla, California (1971-1974), Investigator nalika Howard Hughes Medical Institute (1997-2012), gayut gelar professor saking University of Texas MD Anderson Cancer Center, Houston, Texas (2012), guru wonten ing University of Texas System Cancer Center (1977-1984), Guru wonten ing University of Barkeley (1985-2004), nyambut damel wonten ing Memorial Sloan- Kettering Cancer Center, New, York (2004-2012), University of Texas MD Anderson Cancer Center, Houston, Texas., Direktur Parker Institute for Cancer Immunotherapy, San Francisco.<ref>{{Cite news|url=https://kompas.id/baca/tokoh/sosok/2018/10/03/temuan-peraih-nobel-allison-dan-honjo-amunisi-baru-untuk-perangi-kanker/|title=Temuan peraih nobel Allison dan Honjo amunisi baru untuk perangi kanker|last=Ramadhan|first=Adhitya|date=2018-10-03|work=Kompas|access-date=2019-10-04|archive-url=|archive-date=|dead-url=}}</ref>